Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Total Current Liabilities (2021 - 2026)

bioAffinity Technologies has reported Total Current Liabilities over the past 6 years, most recently at $3.2 million for Q1 2026.

  • Quarterly Total Current Liabilities fell 6.75% to $3.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Mar 2026, down 6.75% year-over-year, with the annual reading at $2.9 million for FY2025, 6.4% down from the prior year.
  • Total Current Liabilities was $3.2 million for Q1 2026 at bioAffinity Technologies, up from $2.9 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $3.4 million in Q1 2025 and troughed at $775151.0 in Q2 2023.
  • The 5-year median for Total Current Liabilities is $2.3 million (2024), against an average of $2.2 million.
  • Year-over-year, Total Current Liabilities tumbled 91.27% in 2022 and then soared 200.11% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $1.1 million in 2022, then surged by 97.41% to $2.2 million in 2023, then soared by 38.13% to $3.1 million in 2024, then fell by 6.4% to $2.9 million in 2025, then grew by 9.59% to $3.2 million in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Total Current Liabilities are $3.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.4 million (Q3 2025).